Evoke Group’s expansion drive continues with West Coast agency buy

Two businessmen shaking hands in a hallway
The Evoke Group pharma and healthcare agency group continues its growth streak, adding West Coast agency Giant. (Getty/Sam Edwards)

Evoke Group has acquired Giant Creative Strategy, adding new geography, expertise and employees as it continues an aggressive growth strategy. The addition of the West Coast full-service healthcare agency adds 150 people to Evoke Group’s roster.

The added heft will help to better position Evoke in the competitive pharma and healthcare agency world, especially as clients increasingly look to consolidate agency partners. Giant’s focus on professional and multichannel marketing along with data and analytics offerings will help Evoke in that pursuit.

“Clients continue to look for opportunities to work with fewer agency partners on larger remits—consolidating business to those with proven and differentiated credentials and expertise in all key brand areas. … [T]he addition of Giant adds an even more robust and differentiated HCP marketing offering to the group, as well as expanded geographic reach," Evoke Group CEO Reid Connolly said in a news release.

Evoke said its group is posting some of the fastest growth in the industry, and it now counts five locations across the United States and Europe. 

RELATED: As Eli Lilly moves some marketing in-house, should ad agencies brace for fallout?

Evoke Group launched in 2015 as a platform to grow the core Evoke Health healthcare agency, headquartered in New York, and build out new agency brands. In its first two years, the Group launched Firsthand, Traverse and Fabric.

Earlier this year, it added agencies nitrogen health and Tonic with offices in both the U.S. and U.K. At the time, Evoke reported it was now working with 18 of the top 20 pharma companies worldwide. Evoke Group is part of the Huntsworth global healthcare and communications group based in the U.K.

Suggested Articles

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.

Pfizer's Upjohn has reached a deal to exclusively supply generic Viagra to telehealth provider Roman as the company prepares to merge with Mylan.